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Abstract
Background: Although viral RNA constitutes the majority of nucleic acids packaged in virions, a late occurring step of
reverse transcription leads to the presence of infectious viral cDNA in foamy virus particles. This peculiarity distinguishes
them from the rest of the retroviral family.
Principal Findings: To evaluate the respective contribution of these viral nucleic acids in the replication of foamy viruses,
their fate was studied by real-time PCR and RT-PCR early after infection, in the presence or in the absence of AZT. We found
that an early reverse transcription step, which occurs during the first hours post-entry, is absolutely required for productive
infection. Remarkably, sensitivity to AZT can be counteracted by increasing the multiplicity of infection (moi). We also show
that 2-LTR circular viral DNA, which appears as soon as four hours post-infection, is transcriptionally competent.
Conclusion: Taken together, our data demonstrate that an early reverse transcription process, which takes place soon after
viral entry, is indispensable for infectivity of FVs at low moi, when the amount of DNA-containing particles is not sufficient to
lead to a productive infection. This study demonstrates a key role of the packaged viral RNA in the foamy virus infection,
suggesting that the replication of this virus can be achieved by involving either viral DNA or RNA genome, depending on
the condition of infection.
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Introduction
Foamy viruses (FVs) are complex animal retroviruses sharing
homologies in comparison to the conventional replication pathway
of retroviruses such as HIV-1. For example, it has been reported
that primate foamy virus (PFV-1) integrase, which is responsible
for the indispensable integration step of the viral genome into the
host cell DNA, displays a new specific restriction-like cleavage
activity on palindromic sequences. An analogous function has also
been demonstrated for Human immunodeficiency virus type 1
(HIV-1) integrase [1-4]. However, Foamy viruses present several
features that set them apart among this viral group [5]. For
example, the Gag polyprotein of FVs, which is involved in the FV
integration process, is not processed into matrix, capsid and
nucleocapsid sub-domains as in most animal retroviruses, but
instead is C-terminally cleaved by the viral protease [6-8], in a
manner similar to the processing of yeast retrotransposon Ty1 Gag
[9]. However, the most striking feature of FVs stands on their
replication strategy, which resembles in some aspects to that of
hepadnaviruses [10]. In particular, full-length infectious viral DNA
is found in extracellular FV particles, demonstrating that part of
viral genomic RNA is reverse transcribed after proviral integration
in producer cells and incorporated into virions [10–12].
Consequently, whereas packaged viral DNA is less than 0.001%
in the case of HIV-1 [13], it can represent as much as 20% of total
viral nucleic acids in extracellular FVs, suggesting that viral DNA
could be functionally important for productive infection [14].
Treatment of target cells with zidovudin (AZT) prior to infection
had only a minor effect on FVs infectivity, strongly suggesting that
incoming viral DNA is sufficient to support efficient replication
[12]. However, the presence of a majority of viral RNA in virions
raises concern about the biological role of these molecules in the
replication cycle of FVs. Indeed, the presence of infectious viral
DNA in extracellular virions does not exclude the existence of an
early, post-entry, reverse transcription step. By quantitative real-
time PCR, we demonstrated the existence of a biphasic viral DNA
synthesis in target cells following infection, which was inhibited by
AZT [15].
Here, the fate of viral DNA and RNA was studied during the
early stages of PFV infection, in the presence or absence of AZT.
Using real-time PCR and RT-PCR, we clearly demonstrated that
an early reverse transcription step is absolutely required for
productive PFV infection. Furthermore, we also reported that 2-
LTR circles, which are described as dead-end products of
retroviral replication, are actively transcribed as already shown
for HIV-1 [16]. Taken together, our study demonstrates the
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infection.
Results
Nucleic acid composition of PFV virions
Although RNA represents the vast majority of the nucleic acid
incorporated in FV particles [12,14], full-length viral DNA was
detected in extracellular virions, representing between 10 and 20%
of packaged nucleic acids [12,14]. Since previous estimations were
mainly based on semi-quantitative approaches [12,14] or
Southern-blot [12], quantitative PCR and RT-PCR were
performed on cell-free virus stocks to precisely measure the viral
DNA and RNA contents of extracellular particles (Fig. S1). For
that purpose, viral supernatant from acutely PFV-infected FAB
cells [17] was pelleted following sucrose gradient centrifugation as
already described [15]. DNAse and RNase treatment were
performed without permeabilization of viral particles in order to
remove free nucleic acids. Following extraction of total genomic
nucleic acids, all viral RNA forms were quantified by real-time
RT-PCR using the TaqMan technology (see Table S1 for primers
and probes sequences). RNA quantifications were also performed
with gag-specific primers which gave the same results in
comparison to those performed with primers and probes Spuma
A, Spuma S and Spuma TM (data not shown). This observation
suggests that the viral RNA extracted from purified FVs viral
particles is a full-length RNA coding for the entire genome. This
hypothesis has been reinforced by the functional role of this viral
RNA (see next section). A very weak signal was obtained when the
reverse transcription step was omitted, testifying the absence of
viral DNA following RNA extraction (Fig. 1). Given these
stringent controls, we confirmed that viral RNA represented the
main nucleic acid detected in extracellular PFV particles (Fig. 1).
Since a viral particle contains 2 copies of the viral RNA [18], we
estimated that DNA-containing viral particles represented about
6% of total viral particles in our experimental settings, consistent
with previous reports. To calculate the percentage of viral RNA in
FVs viral particles, we divided the number of viral RNA copies
from RNase treated particles over the viral DNA copies from the
same amount of DNase-treated particle. Interestingly, LTR-LTR
DNA junctions were also detected (as already reported [15]) in
0.3% of DNA-harboring particles virions. These observations
raised the question of the potential role of RNA in the foamy virus
replication strategy but also the origin of the LTR-LTR junction
detected in virions.
Evidence of an early reverse transcription step
To evaluate the role of the different viral nucleic acids species
packaged in virions during viral replication, the fate of intracellular
viral DNA and RNA was monitored during the first 24 hours post-
infection of human U373-MG cells, at an MOI of 0.01. At
different time points, cells were collected, washed thoroughly and
treated with trypsin to eliminate viral particles that had not been
internalized, as already reported [16].
Since AZT is the only efficient inhibitor of FV RT [19], target
cells were treated or not with this compound (AZT 100 mM) prior
and during infection. We checked that, at the experimental
settings (MOI=0.01), AZT efficiently blocked viral replication as
demonstrated by X-Gal staining of infected cells, as already
reported [15]. A fast increase in intracellular viral RNA content
was observed in the first hours post-infection (hpi), both in the
presence or absence of AZT, most likely corresponding to
incoming viral RNA. This result demonstrates that AZT treatment
did not interfere with viral entry (Fig. 2A). Viral RNA content
reached a maximum of 5.5610
4 copies per 10
6 cells one hour
post-infection. This was immediately followed by a slow decrease
to reach a plateau at 2610
4 copies per 10
6 cells and 0.5610
4
copies per 10
6 cells, in the presence or in the absence of AZT,
respectively (Fig. 2A). In three independent experiments, viral
RNA content in infected cells after viral entry was always higher
when cells were AZT-treated.
On the other hand, viral DNA content, in untreated cells,
increased until 10 hpi and next declined until 24 hpi to reach
2610
4 copies per 10
6 cells (Fig. 2B). This decrease is certainly a
multi-parameter process due to the dilution of viral nucleic acids
following cell division but also to the intrinsic stability of viral
DNA in the infected cell, as already reported for HIV-1 [20]. In
the presence of AZT, a faint signal was detected in the first hpi
reaching 1.2610
3 copies per 10
6 cells, which likely represented
incoming packaged viral DNA [14]. However, under these
settings, the DNA content rapidly reached a plateau at 500 copies
per 10
6 cells (Fig. 2B).
Integrated PFV DNA was quantified by Alu-LTR real-time
PCR as already described [21]. Proviral DNA was detected as
soon as 6 hpi, as already reported for HIV-1 [16], and increased
significantly to reach a maximum of 800 copies per 10
5 cells,
representing about 40% of total viral DNA content at 24 hpi
(Fig. 2C). As expected, no integrated viral DNA could be detected
in the presence of AZT, even at late time points (data not shown).
To normalize the viral RNA quantification we chose the
cyclophilin A mRNA that was reported to be unaffected by
various drugs or viral infection [22]. Assuming that de novo
transcription did not occur at least during the first 10 hpi, as
demonstrated for other retroviruses [16,23], the curve standing for
viral RNA content under AZT treatment reflected the intrinsic
stability of incoming viral RNAs in the infected cell since DNA
synthesis is inhibited. In contrast, the curve representing the RNA
content in the absence of AZT resulted from two concomitant
processes, i.e. the intrinsic stability of viral RNAs in the cytoplasm
and their involvement in an early reverse transcription step
explaining the fact that higher amounts of viral RNA are detected
in the presence of the RT inhibitor, in a reproducible manner.
Figure 1. Characterization of the nucleic acid content of
purified PFV particles. Copy numbers of DNA (linear and 2-LTR
circles) and RNA were determined by real-time PCR and RT-PCR. Each
quantification has been performed in triplicate. However, the standard
deviation is too weak to be indicated. Viral supernatants were treated
with DNase or RNase. The quantification of viral RNA without reverse
transcription is indicated as a control. Results were expressed in copies
per ml of supernatant.
doi:10.1371/journal.pone.0011023.g001
RNA and DNA in PFV-1 Infection
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can thus be estimated as the difference between the viral RNA
content under AZT treatment and that measured in untreated
cells. Remarkably, at each time point, the number of viral RNA
molecules that disappeared correlated with the number of DNA
molecules synthesized (Fig. 2D). Altogether these observations
demonstrated the existence of an early reverse transcription step.
Stability of viral nucleic acids
To examine stability of viral DNA and RNA, U373-MG cells
were infected at a MOI of 0.1 in the absence or presence of
100 mM AZT (Fig. 3). We monitored levels of viral DNA forms as
well as viral RNA over a 6 days period. Viral nucleic acids were
quantified from PFV-infected cell extracts. In the presence of
AZT, viral DNA decreased to reach a steady state of 10
3 copies
per 10
6 cells (Fig. 3A). In the absence of AZT, we observed a
strong viral DNA synthesis due to the spread of the viral
replication. Interestingly, we are able to detect viral DNA until 6
days post-infection. Furthermore, 2-LTR circles also decreased to
reach a steady state of 10
2 copies per 10
6 cells (Fig. 3B).
Consequently, in this condition, the percentage of 2-LTR circles is
increased in the presence of AZT to reach 16% of total viral DNA
(Fig. 3C). Monitoring of viral RNA synthesis demonstrate strong
activity of transcription in the absence of reverse transcription
inhibitor (Fig. 3D). In the presence of AZT, viral RNA was still
detected. This could result from the transcriptional activity of the
incoming viral DNA or the remaining incoming viral RNA.
However, no integrated viral DNA is detected in this condition.
These data reinforce the idea of the transcriptional activity of
unintegrated PFV viral DNA as demonstrated in HIV-1 infection
[16].
Transcriptional activity of 2-LTR circles
Integrated viral DNA is not the only viral nucleic acid
competent for viral gene expression [24]. Indeed, unintegrated
viral DNA can also sustain efficient transcription [25,26], as it
has been recently reported for 2-LTR circles during HIV-1
replication [16]. Consequently, viral RNA synthesized from the
upstream R region contains the U5-U3 junction (Fig. 4A). We
assessed whether such circular viral molecules could generate
LTR-LTR transcripts during PFV replication. For that purpose,
we designed a RT-PCR assay with the same primers used to
measure the LTR-LTR DNA junction. Synthesis of U5-U3
transcripts was initially detected 10 hpi and increased regularly,
reaching a peak 150 hpi with 5610
7 copies per 10
6 cells (1% of
total viral RNA) (Fig. 4B). The U5-U3 transcripts raised to the
same extent as the total viral RNA during the course of infection
(Fig. 4B). Following addition of AZT at 10 hpi, U5-U3
transcripts were still detected in infected cells, representing
10% of total viral RNA content (Fig. 4C). The over-
representation of U5-U3 mRNA under these settings correlated
to that of 2-LTR circles (data not shown and [15]) suggesting
Figure 2. Kinetic analysis of PFV RNA and DNA synthesis. A representative experiment is shown. U373-MG cells were infected in the presence
or absence of AZT (100 mM). The drug was added 2 hours before infection and kept on cells during the experiment. Levels of intracellular PFV DNA
and RNA were monitored during the first hours of infection. (A) Dynamics of viral RNA with and without AZT monitored by real-time RT-PCR.
Synthesis and fate of total viral DNA (B), integrated DNA (C) monitored by real-time PCR. Viral RNA involved in the reverse transcription step as well as
viral DNA synthesis were monitored (D). At each time point post-infection, quantification of viral RNA copies without AZT is subtracted from viral RNA
copies with AZT.
doi:10.1371/journal.pone.0011023.g002
RNA and DNA in PFV-1 Infection
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forms of viral DNA.
Sensitivity to AZT depends on virus dose
Absence of proviral integration and DNA synthesis under AZT
treatment demonstrated total inhibition of FV replication. This
finding, which confirmed our previous observations [15], is in
contrast with other reports showing that AZT has low to weak
effect on FV replication when added during infection [11]. One
hypothesis to explain this discrepancy relies on distinct viral DNA
contents of virus stocks. To assess this possibility, BHK21GFP-
indicator cells (called FAG cells [27]) were infected with increasing
MOI of PFV (raising therefore the amount of incoming viral
DNA) in the presence of AZT. Since FAG cells stably harbor the
GFP reporter gene under the control of the PFV LTR, infection
will lead to GFP expression, which is easily measured by flow
cytometry 48 hpi. In the absence of AZT, GFP-positive cells
represented 52, 84 and 92% of the cell culture following infection
with a MOI of 0.1, 1.4 and 2, respectively. In the presence of the
RT inhibitor, 2% of GFP-positive cells were detected at MOI 0.1,
confirming previous results [15]. This percentage reached 20% at
higher MOI (Fig. 5), demonstrating that sensitivity to AZT
depended on the initial viral stock input, and therefore the amount
of incoming viral DNA.
Discussion
In this report, using real time RT-PCR and PCR assays, we
confirmed the presence of a majority of viral RNA in extracellular
FVs particles. Moreover about 6% of virions released from acutely
infected cells contained viral DNA, including 2-LTR circles.
Studying the fate of incoming viral nucleic acids in PFV-infected
cells, we confirmed the existence of an early viral DNA synthesis
step, which was abrogated under AZT treatment. Remarkably, the
kinetics of viral DNA synthesis correlated with the decrease in viral
RNA content, demonstrating for the first time the importance of
an early reverse transcription step for FV replication.
Previous reports demonstrated that FV reverse transcription
occurred late in the replication cycle [10-12], leading to the
presence of full-length viral DNA in extracellular particles. DNA
extracted from these particles can lead to virus production after
transfection [10]. Consequently, treatment of cells by AZT prior to
infection did not drastically affect viral replication. However,
careful examination of previous reports clearly shows that AZT
did not totally abrogate FV replication. Moebes and al.
demonstrated, in the case of BHK-21 infection, that the titer of
pcHSRV2 virus was 3.63610
3/ml in the absence and 9.5610
1/ml
in the presence of AZT, representing a decrease of 36-fold
decrease of infectivity in the presence of the inhibitor [11]. Our
data demonstrate that viral RNA is also infectious and clearly
show that sensitivity to AZT is dependent on the initial amount of
incoming viral DNA. At a low MOI, the ratio of infected cells
between treated and untreated conditions is 26 but only 4 when
the MOI is 2. Therefore, we suggest that incoming viral DNA can
overcome the inhibitory effect of AZT at higher MOI. Based on
previous reports and on the present study, we propose that FVs
can use two distinct replication strategies depending on the target
cell, as already suggested [28]. The first one requires a step of early
Figure 3. Kinetic analysis of PFV RNA and DNA synthesis over 6 days post-infection. U373-MG cells were infected in the presence or
absence of AZT. Viral DNA (A), 2-LTR circles (B), viral RNA (C) were monitored by real-time PCR and RT-PCR. The percentage of 2-LTR circles over linear
viral DNA is represented (C).
doi:10.1371/journal.pone.0011023.g003
RNA and DNA in PFV-1 Infection
PLoS ONE | www.plosone.org 4 June 2010 | Volume 5 | Issue 6 | e11023Figure 4. Transcriptional activity of 2-LTR circles. Primers used for the quantification of U5-U3 transcript are indicated. (A). The U5, R, U3
regions of the 2-LTR circles are represented. Arrowheads indicate transcription start sites. Kinetics of total viral RNA as well as U5-U3 transcript
content were evaluated during a multiple round of infection of U373-MG cells in the absence (B) or presence of AZT (C).
doi:10.1371/journal.pone.0011023.g004
Figure 5. Effect of increasing MOI on infectivity under AZT treatment. Indicator FAG cells were infected with increasing MOIs in the
presence or absence of AZT at two different concentrations, 10 mM and 100 mM. Forty eight hpi, GFP expression was monitored by flow cytometry.
The values represented the average of three independent experiments.
doi:10.1371/journal.pone.0011023.g005
RNA and DNA in PFV-1 Infection
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to packaged infectious viral DNA. Infection process depends on
the nature of the incoming viral nucleic acid in the infected cell.
Under our settings, we demonstrate that, even a high
concentration of AZT, viral genome is detected even 6 days
post-infection. Unintegrated viral DNA is described to have a
short half life in infected cells but quite stable in quiescent cells
[29,30]. Detection of viral DNA could be due to a basal replication
due to the inefficiency of the compound to prevent totally the
reverse transcription process. Thus, a weak integration could occur
and be at the origin of viral replication. A second hypothesis could
involve the infectious viral DNA packaged in the virions. Further
investigations are needed to conclude between these two
hypotheses. However, in these settings, the percentage of 2-LTR
circles is increased, consistent with a stronger stability of 2-LTR
circles over linear unintegrated viral DNA [31]. Integrated viral
DNA is described to be the sole template for efficient viral
transcription. However, it has been demonstrated that human
macrophages support persistent transcription from unintegrated
HIV-1 DNA [32] highlighting the role of unintegrated viral DNA.
In this report, we found a greater stability of 2-LTR circles over
linear viral DNA in the case of PFV infection associated with
specific transcription from these episomes. The precise role of 2-
LTR circles, detected in viral particles, in the PFV replication
needs to be studied because of the presence of infectious viral
genome in PFV virions. Detection of such molecules in viral
particles could be due to the endogenous reverse transcription or
packaging of 2-LTR circles DNA in particles. Taken together, our
data highly suggest that the two nucleic acids contained in PFV
viral particles are able to lead to viral infection.
Materials and Methods
Cell culture and virus stocks
U373-MG, FAG and FAB cells (harbouring the HFV LTR-b-
Gal construct [17]) were cultured in Dulbecco’s modified Eagle
medium with 10% foetal calf serum. For FAB cells, 1 mg/ml of
G418 (Sigma, Saint Quentin Fallavier, France) was added. Cell-
free virus stocks were titrated on FAB cells as described [17]. In
some experiments, cells were treated with 100 mM AZT (SIGMA,
Saint Quentin Fallavier, France). For pre-treatment experiment,
AZT was added in the medium 2 hours before infection.
Virus and nucleic acid purifications
Cell-free supernatant from acutely infected FAB cells was mixed
with NTE buffer (100 mM NaCl, 10 mM Tris-HCl pH 7.4,
1 mM EDTA) placed on a 20% sucrose cushion and centrifuged
(25,000 rpm, 3 hours, 4uC) using a SW41 rotor. Pellets were
resuspended in PBS and aliquots were treated, or not, with 450
units of DNAse (Gibco, Cergy Pontoise, France) for 5 hours at
37uC or with Rnase A (40 mg/ml) during two hours at 37uC. DNA
was extracted using the DNA Blood Mini kit (Qiagen, Courta-
boeuf, France) and RNA was extracted using the RNeasy mini kit
(Qiagen), according to the manufacturer’s instructions. For
analysis of RNA contained in virions, 5610
6 U373-MG cells
were incubated with 200 ml of viral supernatant to act as a RNA
carrier and lysed immediately by adding 600 ml of RLT buffer
with b-mercaptoethanol (Qiagen). Then, RNA was recovered
according to the manufacturer’s instructions in 50 ml RNase-free
water.
Real-time PCR quantification
Amplification was performed by real-time PCR using the Light
Cycler Instrument (Roche Diagnostics, Meylan, France) and
measurements were performed using the Light Cycler quantifica-
tion software version 3.5 (Roche Diagnostics). Sequences of all
primers used for DNA and RNA quantifications are given in
Table S1. Total PFV DNA was measured using primers in the gag
gene described previously [15]. Two-LTR circles were amplified
using primers spanning the LTR-LTR junction. These amplifica-
tions were realised in a 20 ml reaction volume containing 1X Light
Cycler Fast Start DNA Syber Green Technique (Roche
Diagnostics), 3.5 mM MgCl2, and 500 nM of each primer. The
pHSRV13 plasmid harbouring the entire HFV genome was used
for calibration of total viral DNA quantification. For 2-LTR circles
quantification, the pR/U3 plasmid, obtained by cloning this
413 bp PCR product, was used for calibration. Integrated HFV
DNA quantification was performed by using an Alu-LTR nested
PCR as described previously [21]. Briefly, in the first-round PCR,
Alu-LTR sequences, derived from integrated proviruses, were
amplified in a 20 ml reaction mixture containing 1x Light Cycler
Fast Start DNA Master Hybridation probes (Roche), 4 mM
MgCl2, 100 nM of forward primer LambdaT-SpA and 300 nM of
primers Alu 1 and Alu 2. Nested PCR was performed on 1/10 of
the first-round PCR products in 1x Light Cycler Fast Start DNA
Master Hybridisation probes, 4 mM MgCl2, 300 nM of forward
primer LambdaT, 300 nM of primer Nested R and 200 nM of
each hybridisation probes Sp FL and Sp LC (Table S1). To
quantify integrated HFV copies a standard curve generated by the
concomitant two-rounds PCR amplification of serial dilutions of
the standard U373-MG chronically infected cells. We determined
by serial dilutions of DNA and by Southern Blotting (data not
shown) that viral DNA was exclusively present as integrated forms
in cells. To control linear amplification arising from LambdaT-
SpA primer, we performed a whole PCR protocol omitting Alu
primers in the first round of PCR. Copy number of proviral DNA
in each sample is determined by subtracting integrated DNA
quantification in absence of Alu primers from copy number
measured in presence of Alu primers. All results were reported for
an equivalent number of cells by quantification of the b-globin
gene (2 copies per diploid cell) using commercial available
materials (Control kit DNA, Roche Diagnostics). All PCR
conditions are given in Table S1.
Quantification of viral and cellular RNA
QuantificationsofviralandcellularRNAwereperformedbyusing
real-time RT-PCR protocol. Amplification of viral RNA was
achieved by using the TaqMan technology (Fig. 1D). Two-LTR
transcripts as wellas Cyclophilin A RNAwereperformed using Light
Cycler Hybridisation probes. Sequences of primers and probes are
given in Table S1. All RT-PCR are performed in 1x Light Cycler
RNA Master Hybridisation probes (Roche Diagnostics), 3.25 mM
Mn(OAC)2and 500 nM of each primers and 200 nM of probes. RT-
PCR cycle conditions are given in Table S1. Quantification of viral
and cellular RNA were determined in a reference to a standard curve
prepared by serial dilutions of an in vitro transcribed RNA (RiboMAX
Large Scale RNA production system, Promega, Charbonnie `res,
France) containing matching sequences. Normalization of results was
performed measuring Cyclophilin A RNA. RT-PCR protocol was
performed by hybridation probes technology using a standard curve
generated by serial dilutions of RNA prepared by an in vitro
transcribed RNA.
Supporting Information
Table S1 Primer, probe sequences and PCR and RT-PCR cycle
conditions.
Found at: doi:10.1371/journal.pone.0011023.s001 (0.26 MB PDF)
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1 RNA and DNA quantification. Primers used to quantify total
viral DNA (A) are located in the gag gene. Primers spanning the
LTR-LTR junction were used to detect 2-LTR circles (B).
Integrated DNA (C) is measured by two rounds of PCR as
described previously [21]. Viral RNA species are depicted (D).
Primers used in the RT-PCR strategy monitored all viral RNA
species.
Found at: doi:10.1371/journal.pone.0011023.s002 (1.27 MB EPS)
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